BRCA2 gene mutation
Jump to navigation
Jump to search
Introduction
Complications
- cumulative risk for breast cancer by age 80
- cumulative risk for ovarian cancer by age 80
More general terms
Additional terms
- BRCA1/BRCA2 genotyping
- BRCA2 gene mutation positive
- breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein, BRCA2, FACD, FANCD1)
References
- ↑ 1.0 1.1 Kuchenbaecker KB, Hopper JL, Barnes DR et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017 Jun 20; 317:2402. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28632866 <Internet> http://jamanetwork.com/journals/jama/article-abstract/2632503